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Ampicillin-resistant Enterococcus faecium (ARE) has rapidly emerged worldwide and is
one of the most important nosocomial pathogens. However, very few reports are available
on ARE isolates from canine clinical cases. The objective of this study was to characterize
ARE strains of canine clinical origin from a veterinary teaching hospital in Canada and
to compare them with human strains. Ten ARE strains from dogs and humans were
characterized by multilocus sequence typing (MLST), pulsed field gel electrophoresis
(PFGE), antibiotic susceptibility and biofilm activities, presence of rep-families, CRISPR-
cas and putative virulence genes. All ARE strains (n = 10) were resistant to ciprofloxacin
and lincomycin. Resistances to tetracycline (n = 6), macrolides (n = 6), and to high
concentrations of gentamicin, kanamycin and streptomycin (n = 5) were also observed.
Canine ARE isolates were found to be susceptible to vancomycin whereas resistance
to this antibiotic was observed in human strains. Ampicillin resistance was linked to
PBP5 showing mutations at 25 amino acid positions. Fluoroquinolone resistance was
attributable to ParC, GyrA, and GyrB mutations. Data demonstrated that all canine ARE
were acm (collagen binding protein)-positive and that most harbored the efaAfm gene,
encoding for a cell wall adhesin. Biofilm formation was observed in two human strains
but not in canine strains. Two to five rep-families were observed per strain but no CRISPR
sequences were found. A total of six STs (1, 18, 65, 202, 205, and 803) were found with
one belonging to a new ST (ST803). These STs were identical or closely related to human
hospital-associated lineages. This report describes for the first time the characterization
of canine ARE hospital-associated strains in Canada and also supports the importance of
prudent antibiotic use in veterinary medicine to avoid zoonotic spread of canine ARE.
Keywords: Enterococcus faecium, clinical cases, antibiotic resistance, virulence, plasmid, hospital-associated,
community-associated, MLST
INTRODUCTION
Multiresistant Enterococcus faecium has become one of the most
important nosocomial pathogens, causing increasing numbers of
nosocomial infections worldwide (Willems et al., 2012). They
now represent up to one-third of enterococcal infections (Willems
and Van Schaik, 2009). A multilocus sequence typing (MLST)
study of E. faecium isolates revealed the existence of a dis-
tinct genetic subpopulation associated with nosocomial infec-
tions which was named clonal complex 17 (CC17) (Willems
et al., 2011). Recently, other studies (Van Schaik and Willems,
2010; Van Schaik et al., 2010; De Regt et al., 2012; Willems
et al., 2012) have indicated that these hospital-associated E. fae-
cium (HA E. faecium) did not evolve from a single founder
[i.e., sequence type (ST) 17] as there are now several founders
identified. More recently, a Bayesian population genetic analysis
revealed that HA E. faecium could be divided into three lineages
originating from STs 17, 18 and 78, all ampicillin resistant and
with variable resistance phenotypes to other antibiotics (Willems
et al., 2012).
Genome-wide analyses have shown that HA ARE have a
genetic repertoire distinct from E. faecium strains that asymp-
tomatically colonize the intestinal tract of both humans and
animals in the community (Leavis et al., 2007; Van Schaik et al.,
2010) and are found only sporadically among non-hospital iso-
lates (Willems et al., 2011). However, previous studies around the
world (Damborg et al., 2008, 2009; De Regt et al., 2008, 2012;
Ossiprandi et al., 2008; Jackson et al., 2009; Kwon et al., 2012)
have revealed that healthy dogs are known community reser-
voirs where some of these typical hospital clones seem to reside.
Furthermore, HA ARE have been recovered from clinical cases of
urinary tract infections in canines from the U.S. (Simjee et al.,
2002), Korea (Kwon et al., 2012) and Denmark (Damborg et al.,
2008) and from feces of canines leaving the intensive care unit of
an American veterinary medicine teaching hospital (Ghosh et al.,
2011). In general, only limited data is available on lineages and
genotypic content of HA ARE from canine clinical isolates.
A recent report from Canadian human cases of HA ARE
(McCracken et al., 2013) has indicated that a shift in ST has
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occurred after 2006 and that around that time bacteraemia rates
began to rise in central and western Canada, suggesting a possi-
ble correlation. Prior to 2006, predominant types included ST154,
ST16, ST17 and ST80 and after 2006, ST18, ST203, ST412 and
ST584 became predominant in Canada (McCracken et al., 2013).
In Canada, no data is available on ARE isolates from dogs with ST
lineages causing nosocomial infections in humans. Thus, the goal
of this study was to characterize canine ARE clinical isolates from
Québec, Canada and to determine their STs. Also, HAARE strains
of human origin were used for comparison to assess possible
genetic relationships between the two sets of strains. This study
underscores the importance of canines as potential reservoirs of
multi-drug resistant HA ARE.
MATERIALS AND METHODS
BACTERIAL ISOLATES AND IDENTIFICATION
Ten E. faecium strains were used in this study (Table 1). Dog’
strain isolation criteria were the presence of a relatively recent
(2007–2012) clinical infection, isolation in pure culture, and
PCR identification as E. faecium species. Based on these crite-
ria only five canine E. faecium isolates were recovered over this
period from the diagnostic laboratory of the Faculty of Veterinary
Medicine at the University of Montreal and these were from UTI,
wounds and cholangiohepatitis infections. The human isolates
(n = 5) were provided by the “Centre de Recherche Hospitalier
de l’Université Laval (CRCHUL)” and randomly chosen from a
culture collection of E. faecium from hospitalized patients over
the same period. Some of the human isolates (CCRI no. 18581,
16717 and 16354) were from colonization/surveillance studies
of hospitalized patients. All isolates were identified by multi-
plex PCR assay using species-specific primer sets for the ddl
faecium (ddl F-5′TTGAGGCAGACCAGATTGACG3′ and ddl R-
5′TATGACAGCGACTCCGATTCC3′) identification gene as pre-
viously described (Tremblay et al., 2011). E. faecium HA-56038
was used as a positive control.
ANTIBIOTIC SUSCEPTIBILITY TESTING
Isolates were tested for MIC using the Sensititre plate
CMV3AGPF (Trek™ Diagnostic System Ltd, Cleveland,
OH) according to the Clinical and Laboratory Standards
Institute (CLSI, M31-A3 and M100-S20) guidelines (Clinical
and Laboratory Standards Institute, 2008, 2010). Ciprofloxacin
and ampicillin susceptibilities were further analyzed by standard
broth macrodilution method (CLSI, M31-A3 and M100-S20).
Breakpoints from CLSI and the Canadian Integrated Program
for Antimicrobial Resistance Surveillance (CIPARS) were used
(Anonymous, 2008). Staphylococcus aureus ATCC29213 and
Enterococcus faecalis ATCC29212 were used as control strains.
PFGE AND MLST
Isolates were analyzed for clonal diversity by pulsed-field gel
electrophoresis (PFGE) after SmaI (New England Biolabs, Inc.,
Beverly, Ma, USA) digestion as described by Garcia-Migura
et al. (2005). Digested DNA was electrophoresed as previously
described (Vankerckhoven et al., 2008). Computer analysis of
PFGE banding patterns was performed with Bionumerics Version
6.5 software (Applied Maths, Austin, TX, USA). Banding pattern
similarities were analyzed by the Dice coefficient, and cluster
analysis was performed by the unweighted-pair group method
using average linkages (UPGMA). PFGE types were determined
as = 80% similarity. MLST was based on seven E. faecium
housekeeping genes (atpA, ddl, gdh, purk, gyd, pstS, and adk).
Different sequences were assigned allele numbers, and different
allelic profiles were assigned STs based on the MLST database
(http://www.mlst.net/databases/). Analysis was performed using
the eBURST version 3 algorithm implemented as a Java applet at
http://eburst.mlst.net.
DNA MICROARRAYS
Microarray hybridization experiments were performed as pre-
viously described (Champagne et al., 2011). This enterococ-
cal virulence microarray was developed (Diarra et al., 2010)
at the National Research Council in Montreal and carries 70
taxonomic probes for species identification as well as 15 vir-
ulence factors, and 173 antibiotic resistance probes for a total
of 262 probes. The microarray was used for the detection of
putative target genes. Briefly, bacterial DNA isolated from sin-
gle colonies was labeled with Cy5-dCTP (GE Healthcare, Little
Chalfont, UK). Hybridization, washing, scanning, image pro-
cessing, scoring, and data analysis were done as previously
described (Champagne et al., 2011). Arrays were scanned by
a ScanArray Express microarray Scanner (Packard Biosciences,
Billerica, MA, USA). Oligonucleotide spots with a signal-to-
noise fluorescence ratio above 3 were considered positive. Positive
microarray results were confirmed by PCR with specific primers
for the following genes tet(M), tet(O), tet(L), erm(B), agg and
esp (Table 2). Since erm(AM) and erm(B) shared over 80%
similarity and are perfectly correlated, they were considered as
the same in this study as previously proposed (Roberts et al.,
1999).
PCR DETECTION OF VIRULENCE AND ANTIBIOTIC RESISTANCE GENES
PCR amplifications of virulence genes acm and hyl and of
the quinolone resistance-determining regions (QRDR) genes
were performed as previously described (Nallapareddy et al.,
2003; Vankerckhoven et al., 2004; Billstrom et al., 2008; Werner
et al., 2010). The N-terminal and C-terminal regions of the
pbp5 gene were amplified by PCR (Aarestrup et al., 2002;
Poeta et al., 2007). Both strands of the purified QRDRs
and pbp5 amplicon products were sequenced. Sequences of
gyrA/B and parC/E were compared with the E. faecium DO
genome (GenBank accession no. CP003583) whereas sequences
of the C- and N-terminal regions of pbp5 gene were com-
pared with pbp5 gene reference sequence (GenBank accession no.
X84860).
PCR FOR REPA GENES (PLASMID FAMILIES)
All isolates were screened for rep-like sequences by PCR as
previously described (Jensen et al., 2010) with few modifi-
cations (Table 2). Briefly, fourteen different rep-family plas-
mids (rep1–2, rep4, rep6, rep8–9, rep11, rep13–15, rep16–18 and
repUnique) were tested for their presence in E. faecium isolates.
The PCR amplified and sequenced amplicons from selected
strains (E. faecium strain no. 07-5598, M2146-08, 18581 and
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy August 2013 | Volume 4 | Article 245 | 2
Tremblay et al. Ampicillin-resistant enterococcus faecium
Ta
b
le
1
|C
h
ar
ac
te
ri
za
ti
o
n
o
f
E
.f
ae
ci
u
m
is
o
la
te
s
fr
o
m
h
u
m
an
an
d
ca
n
in
e
en
te
ro
co
cc
al
in
fe
ct
io
n
s.
Is
o
la
te
n
o.
H
o
st
a
S
o
u
rc
es
P
h
en
o
ty
p
ic
re
si
st
an
ce
b
A
n
ti
b
io
ti
c
an
d
re
la
te
d
re
si
st
an
ce
ge
n
ec
V
ir
u
le
n
ce
ge
n
e
B
io
fi
lm
fo
rm
at
io
n
R
ep
-f
am
ily
P
FG
E
p
at
te
rn
S
T
g
ro
u
p
M
LS
T
al
le
lic
p
ro
fi
le
at
p
A
d
d
l
g
d
h
p
u
rK
gy
d
p
st
S
ad
k
07
-5
59
8
D
W
ou
nd
C
H
L,
C
IP
,E
R
Y,
G
E
N
,K
A
N
,L
IN
,
A
M
P,
P
E
N
,S
TR
,
TE
T,
TY
L
aa
c(
6′
)-I
i,
te
t(
M
),
te
t(
L)
,
tr
an
s,
tr
an
s1
ac
m
–
2,
11
,1
8
A
1
20
2
1
1
1
1
1
7
1
M
29
71
-0
8
D
W
ou
nd
C
IP
,E
R
Y,
G
E
N
,
K
A
N
,L
IN
,A
M
P,
P
E
N
,S
TR
,T
ET
,
TY
L
aa
c(
6′
)-I
i,
aa
dE
,
aa
c(
6′
)-I
e-
ap
h(
2′
′ )-
Ia
,
m
sr
C
,t
et
(M
),
te
t(
L)
,
te
t(
O
),
tr
an
s,
tr
an
s1
,
IS
15
0
ef
aA
fm
,
ac
m
–
2,
6,
11
A
2
20
2
1
1
1
1
1
7
1
M
21
46
-0
8
D
B
ile
C
IP
,L
IN
,A
M
P,
P
E
N
,T
ET
aa
c(
6′
)-I
i,
te
t(
M
),
te
t(
L)
,
te
t(
O
),
m
sr
C
,t
ra
ns
,
tr
an
s1
,I
S
15
0
ef
aA
fm
,
ac
m
–
2,
6,
11
,1
4
E
1
80
3
1
1
1
1
1
57
1
M
58
53
-0
9
D
U
rin
e
C
IP
,L
IN
,A
M
P,
P
E
N
,T
ET
aa
c(
6′
)-I
i,
m
sr
C
,t
et
(M
),
te
t(
L)
,t
ra
ns
,t
ra
ns
1
ag
g,
ef
aA
fm
,
ac
m
–
2,
6,
11
,1
4
E
2
80
3
1
1
1
1
1
57
1
M
20
63
8-
11
D
U
rin
e
C
IP
,L
IN
,A
M
P,
P
E
N
aa
c(
6′
)-I
i,
m
sr
C
,t
ra
ns
1
ef
aA
fm
,
ac
m
–
6,
11
,1
4
F
80
3
1
1
1
1
1
57
1
C
C
R
I-1
85
81
H
A
na
l
C
IP
,E
R
Y,
K
A
N
,
LI
N
,A
M
P,
P
E
N
,
ST
R
,T
ET
,T
Y
L,
VA
N
aa
c(
6′
)-I
i,
aa
dE
,
ap
h(
3′
)-I
IIa
,e
rm
(A
M
),
sa
t(
4)
,e
rm
(B
),
m
sr
C
,
te
t(
M
),
va
nA
,v
an
H
,v
an
R
,
va
nS
,v
an
X
,v
an
Y,
tr
an
s,
tr
an
s1
,I
S
11
82
,I
S
15
0
es
p,
ac
m
–
11
,1
4,
17
,
U
ni
qu
e
H
18
7
1
1
1
5
1
1
C
C
R
I-1
63
54
H
R
ec
ta
l
C
IP
,L
IN
,A
M
P,
P
E
N
,V
A
N
aa
c(
6′
)-I
i,
m
sr
C
,t
et
(M
),
va
nB
1,
tr
an
s,
tr
an
s1
,
IS
15
0
ef
aA
fm
,
ac
m
–
1,
2,
14
B
18
7
1
1
1
5
1
1
C
C
R
I-1
67
17
H
S
to
ol
s
C
IP
,E
R
Y,
G
E
N
,
K
A
N
,L
IN
,A
M
P,
N
IT
,S
TR
,T
ET
,
TY
L,
VA
N
aa
c(
6′
)-I
i,
aa
dE
,
ap
h(
3′
)-I
IIa
,e
rm
(A
M
),
er
m
(B
),
sa
t(
4)
,m
sr
C
,
te
t(
M
),
te
t(
L)
,v
an
A
,
va
nH
,v
an
R
,v
an
S,
va
nX
,
va
nY
,r
es
,t
ra
ns
,I
S
11
82
ef
aA
fm
,
ac
m
–
1,
2,
4,
6,
11
D
1
8
4
5
7
1
1
5
C
C
R
I-1
87
07
H
Pu
s
C
IP
,E
R
Y,
G
E
N
,
K
A
N
,L
IN
,A
M
P,
P
E
N
,S
TR
,T
Y
L
aa
c(
6′
)-I
i,
aa
c(
6′
)-I
e-
ap
h(
2′
′ )-
Ia
,
aa
dE
,a
ph
(3
′ )-
III
a,
er
m
(A
M
),
sa
t(
4)
,e
rm
(B
),
m
sr
C
,t
ra
ns
,t
ra
ns
1,
IS
11
82
,I
S
15
0
ef
aA
fm
,
es
p,
ac
m
,
hy
l
+
17
,U
ni
qu
e
C
65
1
2
1
20
1
1
9
(C
on
tin
ue
d)
www.frontiersin.org August 2013 | Volume 4 | Article 245 | 3
Tremblay et al. Ampicillin-resistant enterococcus faecium
Ta
b
le
1
|C
o
n
ti
n
u
ed
Is
o
la
te
n
o.
H
o
st
a
S
o
u
rc
es
P
h
en
o
ty
p
ic
re
si
st
an
ce
b
A
n
ti
b
io
ti
c
an
d
re
la
te
d
re
si
st
an
ce
ge
n
ec
V
ir
u
le
n
ce
ge
n
e
B
io
fi
lm
fo
rm
at
io
n
R
ep
-f
am
ily
P
FG
E
p
at
te
rn
S
T
g
ro
u
p
M
LS
T
al
le
lic
p
ro
fi
le
at
p
A
d
d
l
g
d
h
p
u
rK
gy
d
p
st
S
ad
k
C
C
R
I-1
82
31
H
W
ou
nd
C
IP
,E
R
Y,
G
E
N
,
K
A
N
,L
IN
,A
M
P,
P
E
N
,S
TR
,T
Y
L
aa
c(
6′
)-I
i,
aa
c(
6′
)-I
e-
ap
h(
2′
′ )-
Ia
,
aa
dE
,a
ph
(3
′ )-
III
a,
er
m
(A
M
),
er
m
(B
),
sa
t(
4)
,
m
sr
C
,t
ra
ns
,t
ra
ns
1,
IS
11
82
,I
S
15
0
ef
aA
fm
,
es
p,
ac
m
,
hy
l
+
+
+
17
,U
ni
qu
e
G
20
5
3
1
1
1
1
1
1
a
D
,d
og
s;
H
,h
um
an
s.
b
A
M
P,
am
pi
ci
lli
n;
C
H
L,
ch
lo
ra
m
ph
en
ic
ol
;
C
IP
,
ci
pr
ofl
ox
ac
in
;
E
R
Y,
er
yt
hr
om
yc
in
;
G
E
N
,
ge
nt
am
ic
in
;
K
A
N
,
ka
na
m
yc
in
;
LI
N
,
lin
co
m
yc
in
;
N
IT
,
ni
tr
of
ur
an
to
in
;
P
E
N
,p
en
ic
ill
in
;
ST
R
,
st
re
pt
om
yc
in
;
TE
T,
te
tr
ac
yc
lin
e;
TY
L,
ty
lo
si
n;
VA
N
,v
an
co
m
yc
in
.
c
Id
en
tifi
ed
by
m
ic
ro
ar
ra
y;
aa
c(
6′
)-I
ii
s
in
tr
in
si
c
re
si
st
an
ce
in
E
.f
ae
ci
um
.
W
ea
k
bi
ofi
lm
pr
od
uc
er
(+
)a
nd
st
ro
ng
bi
ofi
lm
pr
od
uc
er
(+
+
+
),
ba
se
d
up
on
th
e
pr
ev
io
us
ly
ca
lc
ul
at
ed
O
D
va
lu
es
(s
ee
M
at
er
ia
ls
an
d
M
et
ho
ds
)
16717) from this study were used as positive controls for
rep1–2, rep4, rep6, rep14, rep17–18 and repUnique whereas control
strains for rep8–9, rep11, rep13, and rep15–16 were from a pre-
vious study (Tremblay et al., 2012). The families’ rep3, rep5,
rep7, rep10, and rep19 could not be tested because no posi-
tive PCR products were obtained and no control strains were
available.
DETECTION OF CRISPR-cas
The CRISPR1-cas and CRISPR3-cas loci were screened by PCR
as previously described (Palmer and Gilmore, 2010) with slight
modifications. Briefly, the PCR reactions were performed in a
total of 50μl, using 80 pmol of each primer, 1.5mM MgCl2,
10mM each of dNTPs, 2 U of Taq DNA, 1X Buffer mix
(New England Biolabs) and sample DNA. Amplification reac-
tions were carried out using a Whatman Biometra thermo-
cycler (Montreal Biotech Inc, Québec, Canada) programmed
as follows: an initial denaturation step of 94◦C for 2min, 30
cycles of denaturation at 94◦C for 1min, annealing for 1min
and extension at 72◦C for 1min, followed by a final elon-
gation at 72◦C for 5min. For visualization, 5μl of the PCR
reaction were subjected to electrophoresis in 1.2% agarose gel
stained with ethidium bromide. A 100 bp ladder (TrackIt,
Invitrogen, Ontario, Canada) was used as a marker. Enterococcus
faecalis strain no. 02-A701 and 06-6225 were used as positive
controls.
BIOFILM FORMATION
Isolates were inoculated in tryptic soy broth (TSB) supplemented
with 1% glucose in 96 well microtiter plates (Fisher scientific)
for bacterial growth and biofilm formation as described else-
where (Zoletti et al., 2011). Biofilm was quantified using crystal
violet staining method as described by Zoletti et al. (2011).
Staphylococcus epidermidis ATCC 35984 (biofilm producer) and
wells containing uninoculated medium were used as controls.
ODs were obtained using a microplate reader Biotek Synergy HT
(Bio-tek Instruments Inc., Winooski, VT, USA) at a wavelength
of 570 nm. Analyses were based on two different experiments
where isolates were tested in triplicate. The quantification of
biofilm formation in microtiter plates was performed as previ-
ously described (Stepanovic et al., 2000, 2007). Briefly, strains
were divided into the following categories: no biofilm producer
(−), weak biofilm producer (+), moderate biofilm producer
(++) and strong biofilm producer (+ + +), based upon the
previously calculated OD values: OD ≤ ODc = no biofilm pro-
ducer; ODc < OD ≤ 2X ODc = weak biofilm producer; 2X
ODc < OD ≤ 4X ODc = moderate biofilm producer; 4X ODc
< OD = strong biofilm producer. ODc is defined as three
standard deviations (SD) above the mean OD of the negative
control.
STATISTICAL ANALYSIS
A chi-square exact test was used to examine the association
between isolate, origin, antibiotic resistance, virulence genes,
biofilm formation, plasmid families and CRISPR genes. Statistical
analyses were carried out using SAS software v. 9.2 (SAS Institute
Inc., Cary, N.C., USA). The level of statistical significance was set
at 0.05.
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Table 2 | Primers and conditions used in PCR for confirmation of microarray results and for rep-like genes identification.
Gene detected or Primers (5′ to 3′)b Amplicon Annealing Reference or
Rep-family no.a (bp) (T◦C) GenBank no.
tet(M) F-GTGGACAAAGGTACAACGAG 406 55 De Leener et al., 2004
R-CGGTAAAGTTCGTCACACAC
tet(O) F-GATGGCATACAGGCACAGAC 614 62 Aarestrup, 2000
R-CAATATCACCAGAGCAGGCT
tet(L) F-ATAAATTGTTTCGGGTCGGTAAT 1077 52 De Leener et al., 2004
R-AACCAGCCAACTAATGACAAGT
erm(B) F-GAAAAGRTACTCAACCAAATA 639 52 Poeta et al., 2005
R-AGTAACGGTACTTAAATTGTTTAC
agg F-GGTGCCACAATCAAATTAGG 380 46 Seno et al., 2005
R-GATTCTTCGATTGTGTTGTAAACG
esp F-TTGCTAATGCTAGTCCACGACC 955 63 Seno et al., 2005
R-GCGTCAACACTTGCATTGCCGAA
1 (pIP501) F-TCGCTCAATCACTACCAAGC 624 52 X17655
R-CTTGAACGAGTAAAGCCCTT
9 (pCF10) F-GCTCGATCARTTTTCAGAAG 201 AY855841
R-CGCAAACATTTGTCWATTTCTT
4 (pMBB1) F-ACTATGTCGTTGAGTCTAATGACT 430 52 U26268
R-AGCAAGATAGAATATTTACTTTTAAGTTT
14 (pRI1) F-RTTTTGRCTTTCTTSYTTCA 164 EU327398
R-TGAAAGYTTRGATAGYTTTGC
17 (pRUM) F-TACTAACTGTTGGTAATTCGTTAAAT 502 EU376117
R-ATCAAGGACTCAACCGTAATT
Unique (pMG1/pHTβ) F-GTATTAACACACTGGACTC 199 52 AB206333
R-TCAGTGTAGGCAATAACCC
2 (pRE25) F-GAGAACCATCAAGGCGAAAT 630 56 X92945
R-ACCAGAATAAGCACTACGTACAATCT
6 (pS86) F-ACGAATGAAAGATAAAGGAGTAG 551 AJ223161
R-TAAATTCTAGTTTGGCAATCTTAT
8 (pAM373) F-CCAATCATGTAATGTTACAACC 394 AE002565
R-TAGATACGACAAAAGAAGAATTACA
18 (pEF418) F-ACACCAGTCGAAATGAATTT 462 AF408195
R-AGGAATATCAAGTAATTCATGAAAGT
13 (pC194) F-TACCAGAATAYTTAGCCATTTC 402 54 V01277
R-ATGATGCAATATATTAAGCA
15 (pUSA03) F-CAGTAGAAGAAAATTATAAAGAAC 327 CP000258
R-GTTATGGCTGGTTTTAATAAA
16 (pSAS) F-CTTCTATATCACTATCATTGTCATT 592 BX571858
R-CAGGAAAACACTTCGTTTAT
11 (pEF1071) F-TCTAGAATGCGTGAAAAAGG 500 54 AF164559
R-CCTTTGAAGATWGCRGTWAG
aRep-family numbers are associated with plasmid in parenthesis.
bF, forward; R, reverse.
RESULTS
MLST AND PFGE
MLST allelic profiles are presented in Table 1. A total of six STs
were found among the E. faecium isolates, ST1 (n = 1), ST18 (n =
2), ST65 (n = 1), ST202 (n = 2), ST205 (n = 1) and one novel,
ST803 (isolates M2146-08, M5853-09 andM20638-11) (Table 1).
Canine ARE belonged to ST202 (n = 2) and ST803 (n = 3) both
SLV of ST17. Human clinical isolates belonged to ST65 (n =
1), a singleton known to be found only among clinical strains
(Werner et al., 2011), and ST205 (n = 1), a SLV of ST17 (Table 1).
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Human surveillance isolates belonged to ST18 (n = 2), and ST1
(n = 1, linked to CC1). Therefore, all these STs were linked to
HA-ARE except for ST1 which was shown to belong to a clus-
ter containing primarily isolates from calves in the Netherlands
(http://efaecium.mlst.net/). Following genomic SmaI digestion
and PFGE, the E. faecium isolates (n = 10) of human and canine
origins produced ten macro-restriction patterns clustered into
eight PFGE types, termed A through H (Table 1). Canine E. fae-
cium isolates of subtypes A and E were ≥ 80% similar whereas the
remaining E. faecium isolates were considered unrelated (≤80%).
The E. faecium PFGE types B and H were set as a same group by
MLST (ST18) whereas the new ST803 was grouped as PFGE types
E and F (Table 1).
ANTIBIOTIC RESISTANCE
Chloramphenicol, ciprofloxacin, erythromycin, lincomycin,
tylosin, gentamicin, kanamycin, streptomycin, penicillin, ampi-
cillin, and tetracycline resistances were observed in E. faecium
clinical isolates of canine origin with no resistance observed to
daptomycin, linezolid, nitrofurantoin, quinupristin/dalfopristin,
vancomycin and tigecycline (Tables 1, 3). Resistances to
ciprofloxacin, erythromycin, lincomycin, tylosin, gentamicin,
kanamycin, streptomycin, nitrofurantoin, penicillin, ampicillin,
tetracycline and vancomycin but not to chloramphenicol,
daptomycin, linezolid, quinupristin/dalfopristin and tigecycline
were observed in human E. faecium clinical isolates (Tables 1, 3).
All E. faecium isolates were resistant to ampicillin, ciprofloxacin
and lincomycin. Seven isolates were considered as high-level
ciprofloxacin-resistant (MICs of > 16μg/ml) whereas nine
isolates showed high-level ampicillin resistance (MICs of ≥
256μg/ml) (Table 3). Also, erythromycin resistance (n = 6)
was positively associated (p-value < 0.05) with aminoglycoside
resistance (n = 6), whereas ciprofloxacin resistance (n = 10)
correlated (p-value < 0.05) with ampicillin (n = 9) resistances.
All vancomycin resistant E. faecium (n = 3) isolates were of
human origin.
MICROARRAY AND PCR ANALYSIS OF VIRULENCE AND ANTIBIOTIC
RESISTANCE GENES
Virulence and antibiotic resistant genotypes are presented in
Table 1. Results demonstrated all canine ARE isolates were acm-
positive but were negative for esp and hyl genes. The majority of
these isolates were shown to harbor efaAfm gene, encoding for a
cell wall adhesin. One canine ARE isolate also had the agg gene
encoding for an aggregation substance of pheromone-responsive
plasmid. The efaAfm gene was detected in all human isolates
but one. The two human clinical isolates (CCRI-18707 and -
18231) were also positive for the glycosyl hydrolase gene (hyl).
Acquisition of multiple antibiotic resistance genes was observed
ranging from 2 to 14 per isolate. Correlation between MICs
and the presence of resistance genes has indicated that tetracy-
cline resistance was attributable to tet(M) (n = 2); tet(M) and
tet(L) (n = 3); and tet(M), tet(L) and tet(O) (n = 2). Resistance
to erythromycin, lincomycin and tylosin could be explained
by the presence of msrC, erm(AM)/ erm(B) in all strains with
the exception of one (07-5598). Streptomycin resistance was
associated with the aadE gene in all strains except one (07-
5598). Kanamycin resistance was explained by aph(3′)-IIIa in
all strains except two (07-5598 and M2971-08) whereas gen-
tamicin resistance was attributable to aac(6′)-Ie-aph(2′)-Ia in all
strains but two (07-5598 and CCRI-16717). Chloramphenicol
resistance (n = 1) could not be explained because both cat
and floR genes were absent in the two canine ARE resistant
isolates. The gene aac(6′)-Ii is intrinsic in E. faecium and confers
Table 3 | Antibiotic resistance of E. faecium clinical isolates from humans and dogs based on MICs.
Antibiotic agent 
Number of isolates at a MIC (µg/ml) ofb % Resistant isolates (b) 
0,06 0,12 0,25 0,5 1 2 4 8 16 32 64 128 256 512 1024 2048 4096 Human Dog 
Chloramphenicol 8 1 1 0 (0) 20 (1) 
Daptomycin 7 3 0 (0) 0 (0) 
Erythromycin 2 2 6 80 (4) 40 (2) 
Gentamicin 5 5 60 (3) 40 (2) 
Kanamycin 4 6 80 (4) 40 (2) 
Lincomycin 10 100 (5) 100 (5) 
Linezolid 9 1 0 (0) 0 (0) 
Ciprofloxacina 1 2 1 2 4 100 (5) 100 (5) 
Nitrofurantoin 1 8 1 20 (1) 0 (0) 
Ampicillina 1 3 6 100 (5) 100 (5) 
Penicillin 1 9 80 (4) 100 (5) 
Streptomycin 4 1 1 4 80 (4) 40 (2) 
Quinupristin/ 
dalfopristin    6 3 1            0 (0) 0 (0) 
Tetracycline 4 1 5 40 (2) 80 (4) 
Tylosin 3 1 6 80 (4) 40 (2) 
Vancomycin 2 5 3 60 (3) 0 (0) 
Tigecyline 5 5 0 (0) 0 (0) 
aCiprofloxacin and ampicillin MICs from the standard broth macrodilution method.
bNumber of isolates; |, MIC breakpoint; bold numbers, numbers of resistant isolates; ‖, susceptible breakpoint; unshaded areas, range of dilutions tested; numbers
in the shaded area, isolates with MICs greater than the highest tested concentrations.
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resistance to low-level aminoglycosides. Also, the transposase
genes trans and trans1 (both GenBank accession no. AF516335)
associated with transposons Tn1546 and Tn5405-like on the
plasmid pUW786 carryingmultiresistance gene cluster were iden-
tified in many isolates (n = 9). A correlation (p-value < 0.05)
was observed between aadE (high-level streptomycin resistance),
aph(3′)-IIIa, (aminoglycoside resistance), sat(4) (streptothricin
acetyltransferase) and IS1182 transposase gene (also associated
with plasmid pUW786) in human isolates of E. faecium (Diarra
et al., 2010). The antibiotic resistance genes erm(AM)/erm(B)
(macrolide-lincosamide-streptogramin B, MLSb), aadE, sat(4),
aph(3′)-IIIa were significantly (p-value < 0.05) associated with
human isolates. Positive associations (p-value < 0.05) were
observed between trans1 and IS150 transposase genes, aac(6′)-
Ie-aph(2′′)-Ia (encoding for a bi-functional aminoglycoside-
modifying enzyme) and erm(AM)/erm(B). No beta-lactamase
genes were detected in this study.
SCREENING FOR gyrA/B AND paRC/E MUTATIONS
Enterococcus faecium isolates spanned a range of ciprofloxacin
MICs from 4μg/ml to > 256μg/ml with seven isolates consid-
ered as high-level ciprofloxacin-resistant (MICs of > 16μg/ml)
(Table 3). High-level ciprofloxacin resistance was attributable to
ParC (Ser80 → Arg, Ile or Asp; and Asn73 → Asp) and GyrA
(Ser83 → Arg, Tyr, or Ile; Met127 → Trp; and Glu87 → Lys)
mutations (Table 4). All high-level ciprofloxacin-resistant isolates
had mutations in both GyrA (Ser83 → Arg or Tyr or Ile) and
ParC (Ser80 → Arg or Ile or Asp). Corresponding fragments
of subunits B (parE/gyrB) were also investigated. Two isolates
demonstrated mutations in GyrB (Asp436→Asn, Leu371→ Trp
and Pro455 → Ser) whereas no changes in ParE were detected
(Table 4). Isolates with MICs of < 16μg/ml did not harbor
mutational changes.
SEQUENCE ANALYSIS OF pbp5
Nine isolates showed high-level ampicillin resistance (MICs of
≥ 256μg/ml) with all canine ARE being high-level. Both the N-
terminal and C-terminal regions were analyzed and revealed that
PBP5 contained 25 amino acid changes, as shown in Table 5. The
insertion of aspartic acid at position 466′ was mostly observed
in isolates of animal origin. Alleles were designated 1-5 based
on important amino acid substitutions in the C-terminal region
with none showing 100% identity with the reference sequence
(GenBank accession no. X84860). The same pbp5 alleles (alleles
1 and 2) were observed in clonal isolates with PFGE patterns A1
and A2 and E1 and E2.
repA GENES (PLASMID FAMILIES)
Nine different rep-family plasmid genes (rep1–2, rep4, rep6, rep11,
rep14, rep17–18 and repUnique) were detected in E. faecium iso-
lates (Table 1). The predominant rep-family among E. faecium
isolates was rep11 (pEF1071) with seven isolates. Other rep-
families were also observed: rep1 (pIP501) (n = 2), rep2 (pRE25)
(n = 6), rep4 (pMBB1) (n = 1), rep6 (pS86) (n = 5), rep14 (pRI1)
(n = 5), rep17 (pRUM) (n = 3), rep18 (pEF418) (n = 1) and
repUnique (pUB101) (n = 3). Overall, rep11 and rep6 families were
significantly (p-value < 0.05) associated with isolates of canine
origin. The families’ rep8–9, rep13, and rep15–16 were not detected.
CRISPR-cas GENES
To determine whether there is an association between CRISPR
elements and plasmid family genes, virulence and/or antibiotic
resistance genes, CRISPR-cas genes were investigated by PCR.
Because potential sequence divergence among csn1 genes, an
internal region of CRISPR-cas locus-specific genes, may lead to
false-negative PCR results, isolates with negative PCR results were
further screened with primers flanking the conserved locations of
the CRISPR1-cas and CRISPR3-cas loci, between homologues of
EF0672-EF0673 and EF1760-EF1759, respectively, as compared
with the E. faecalis genome V583 (Palmer and Gilmore, 2010).
According to Palmer and Gilmore (2010), one CRISPR-cas locus
was identified in three E. faecium genomes. However, this locus
could not be detected in our ten ARE strains. No significant
correlations could be made with the absence of antibiotic resis-
tance, virulence, and plasmid family genes due to low number of
isolates.
Table 4 | Mutations in gyrA/B and parC of clinical E. faecium isolates with their corresponding ciprofloxacin MIC.
Ciprofloxacin MIC (µg/ml) Isolate no. Hosta Amino acidb mutation in gene (codon)
gyrA gyrB parC
4 M2146-08 D None None None
8 M5853-09 D None None None
8 CCRI-16717 H None None None
64 M20638-11 D I (83) N (436) R (80)
128 07-5598 D Y (83), W (127) None I (80)
128 CCRI-18231 H K (87) None I (80), D (73)
>256 M2971-08 D Y (83) None I (80)
>256 CCRI-18581 H Y (83) None R (80)
>256 CCRI-16354 H Y (83) W (371), S (455) I (80)
>256 CCRI-18707 H R (83) None I (80)
aD, dogs; H, humans.
bD, aspartic acid; I, isoleucine; K, lysine; N, asparagine; R, arginine; S, serine; W, tryptophan; Y, tyrosine.
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BIOFILM FORMATION
Both isolates producing biofilm were recovered from infections,
one weak and one strong both harboring the esp gene (Table 1),
contrasting with those from surveillance. However, one ARE
isolate which colonized a hospitalized patient was positive for the
esp gene and did not produce a biofilm.
DISCUSSION
To the best of our knowledge, we describe for the first time, the
characterization of ARE strains of canine origin from Canada
with STs identical (ST202) or closely related (ST803) to human
hospital-associated lineages. Colonization by major clones is rel-
atively rare in healthy humans (De Regt et al., 2012). The pres-
ence in canine clinical cases of identical or closely related ARE
clones currently involved in the nosocomial epidemiology sup-
ports the hypothesis that, cross-transmission between humans
and dogs may potentially occur. This is also why it was decided
to fully characterized these dog strains and compare them with
human strains from Canada. In canines, reports have indicated
that ARE most frequently were of ST266 origin but that a vari-
ety of STs associated with human clinical infections could also
be found (Damborg et al., 2008, 2009; Ghosh et al., 2011; De
Regt et al., 2012). These findings, along with the current study,
present evidence of some genotypic concordance, based onMLST,
between hospital clones of human origin and community ARE
from clinical cases of dogs, indicating that these isolates are
likely evolutionarily linked. This has also been previously sug-
gested by a phylogenomic analysis of two dog strains and seven
sequenced E. faecium genomes derived from humans (De Regt
et al., 2012). Similar to a study on Dutch canine ARE isolates
(De Regt et al., 2012), canine ARE isolates in our study were
not an “exact copy” to those in the circulating Canadian hospi-
tal reservoir as none of the human predominant types in Canada
(McCracken et al., 2013) were identified in these isolates. This
could also be because the number of isolates of this study was
limited.
In humans, the emergence of high-level ampicillin resistance,
specifically in US hospitals in the early 1980s, preceded the
epidemic rise of vancomycin resistance, which occurred in the
1990s, explaining why virtually all vancomycin-resistant entero-
cocci (VRE) recovered from nosocomial infections in humans
are also ampicillin resistant (Grayson et al., 1991; Iwen et al.,
1997). In this study, the transposase genes trans and trans1, associ-
ated with Tn1546, were present in strains of canine origin which
were all susceptible to vancomycin. This could be explained by
possible mutations or deletions within this transposon causing
the susceptible phenotype in canine isolates. Because the associ-
ation between ampicillin and vancomycin resistance phenotypes
in humans probably reflects sequential and independent acqui-
sition of resistance genes resulting in the selective dominance of
a small subset of hospital-adapted clones (Willems et al., 2011),
care should be taken to completly withdraw vancomycin from vet-
erinary medicine and to perform detailed surveillance studies on
possible anthropo-zoonotic transfer of ARE.
In this study, the high-level ciprofloxacin and ampicillin resis-
tances observed were associated respectively with previously
reported amino acid changes in topoisomerase IV, DNA gyrase
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and in PBP5 (Ligozzi et al., 1996; Zorzi et al., 1996; Rice et al.,
2001; Jureen et al., 2003; Werner et al., 2010). To our knowledge,
previous studies did not observe mutations in the gyrB target
(Leavis et al., 2006;Werner et al., 2010; Valdezate et al., 2012). The
contribution of these amino acid changes in GyrB to ciprofloxacin
resistance is difficult to evaluate because amino acid changes in
GyrA and ParC alone are sufficient to confer high-level resistance
to ciprofloxacin. Other resistance mechanisms may be responsible
for (low-level) ciprofloxacin resistance in HAARE isolates that do
not contain amino acid changes in the QRDRs of ParC and GyrA.
Recently, characterization of EfmA, amultidrug efflux pump con-
ferring resistance to quinolones and macrolides, from E. faecium
has been described (Nishioka et al., 2009) which could explain
low-level ciprofloxacin resistance in some of the isolates of this
study.
So far, canine ARE have been shown to carry fewer virulence
traits (De Regt et al., 2012; Kwon et al., 2012) compared to human
HA ARE (Top et al., 2008; Werner et al., 2010). It was also shown
in a recent report that canine E. faecium did not form biofilms
and lacked the strong gelatinase phenotype as well as esp (Ghosh
et al., 2011). Also, as observed in our study, ARE strains that
colonize the gastrointestinal tract of humans have been shown
to carry less determinants such as the enterococcal surface pro-
tein, Esp (Coque et al., 2002; Heikens et al., 2007), genomic
islands (Heikens et al., 2008), and insertion sequence elements
(Leavis et al., 2007). Recently, a sequence-based classification sys-
tem for enterococcal plasmids has been established which targets
replicon-specific plasmid DNA to determine 19 plasmid families
which are associated with either a very narrow or a broader host
range (Jensen et al., 2010). This procedure was attempted to deter-
mine whether specific plasmid families were involved in ARE of
canine origin vs. human origin. In this study, rep6 (small cryptic
plasmids) and rep11 (toxin producing plasmids) plasmid families
were significantly associated with isolates from dogs. Interestingly,
it was also observed that these two families seem to be associated
with human isolates from colonization (CCRI no. 18581, 16717,
and 16354) but due to low number of isolates this statistical signif-
icance could not be addressed. No significant association between
rep families and antimicrobial resistance genes could be identified
for isolates of canine origin whereas the human clinical strains
were significantly associated (p < 0.05) with erm(B)/erm(AM),
aadE, sat(4), aph(3′)-IIIa, IS1182 and with the rep17 plasmid
family which has been previously reported (Grady and Hayes,
2003). Interestingly, these genes were also detected in a surveil-
lance human isolate. Recently, a significant correlation between
the absence of CRISPR-cas loci and the presence of antibiotic-
resistance genes was previously described for E. faecalis (Palmer
and Gilmore, 2010). This tendency was also observed in ARE of
this study but due to the low number of isolates its significance
could not be determined. Further research is needed to assess
the virulence and the antimicrobial resistance of canine strains
in comparison with that of human strains and, more generally,
to quantify the magnitude of this possible emerging zoonotic
problem.
In conclusion, the current study provides the first characteri-
zation of canine clinical ARE isolates in Canada with STs identical
or closely related to human clinical isolates. This analysis, as well
as previous reports, further indicates that canine ARE isolates are
evolutionarily linked with hospital ARE isolates with some dis-
cordance in their multi-drug resistance and virulence attributes.
These findings also support the importance of prudent use of
antibiotics in veterinary medicine to avoid zoonotic spread and
development of vancomycin resistance of canine ARE isolates.
Select and spread of HA-strains that can cause human infections
is a major concern, independently of being VRE, because in some
countries ARE associated with human infections remain van-
comycin susceptible. Further studies are needed to understand the
significance of dogs in the spread of this nosocomial pathogen in
the community. The occurrence of ARE in dogs and other domes-
tic animals could be addressed by national programs in order to
explore the importance of the animal reservoir in the evolution of
human hospital ARE isolates.
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